ADM Strengthening Focus on Sustainability and Innovation in Q4 Results
AgTech Corporate Food Tech Stock Market

ADM News: Publishes Its 2022 CSR Report

Discover the latest news from ADM (NYSE: ADM):

2022 CSR, Showcasing Progress In Key ESG Areas (2023/05/19)

ADM, a global leader in food, feed, fuel, industrial, and consumer products, has released its 2022 Corporate Sustainability Report, highlighting its commitment to sustainability and progress in critical environmental, social, and governance areas. The report outlines ADM’s achievements and goals in three categories: Feeding the World, Protecting Nature, and Enriching Lives. Regarding Feeding the World, ADM has focused on efficient land use, alternative proteins, reducing food waste, and ensuring food safety. Protecting Nature initiatives include traceability, emissions reduction, water conservation, regenerative agriculture, and biodiversity management. Enriching Lives efforts encompass philanthropy, human rights, safety, and corporate culture. ADM’s sustainability efforts demonstrate its dedication to making a positive impact across its value chains and positioning sustainability as a critical component of its growth strategy.

Air Protein Announce Strategic Development Agreement (2023/05/19)

ADM and Air Protein have entered into a Strategic Development Agreement (SDA) to advance research and development efforts in creating innovative proteins for nutrition. The collaboration combines ADM’s nutrition, formulation, and research expertise with Air Protein’s landless agriculture platform. The goal is to develop cost-effective ingredients that meet the nutrition, flavor, and texture targets in meat substitutes. The SDA also includes exclusive rights for ADM and Air Protein to collaborate on building and operating the world’s first commercial-scale plant. ADM has been a strategic investor in Air Protein, providing significant backing for its growth initiatives. Air Protein recently completed a regulatory review confirming the safety of its protein, marking an important milestone in its journey to offer consumers the protein of the future.

Partners With Believer Meats To Develop and Commercialize Cultivated Meat (2023/04/13)

ADM and Believer Meats have partnered to develop, and market cultivated meat products. As a global leader in sustainable nutrition, ADM aims to meet food security and sustainability needs by expanding the protein ecosystem, including cultivated meat. Believer Meats brings its ground-breaking cell-cultivation technology to the collaboration. The partnership will leverage ADM’s ingredient expertise and nutrition solutions to enhance Believer’s proprietary meat production process. The non-exclusive agreement also allows for the potential commercialization of new products, supported by ADM’s processing expertise and footprint. With a shared commitment to sustainability and meeting the demands of a growing population, this collaboration is poised to accelerate the growth and commercialization of cultivated meat, shaping a more sustainable food system for the future.

ADM and Brightseed Partner to Develop Synbiotic Products For Microbiome Optimization (2023/04/10)

ADM, a leader in nutrition around the world, and Brightseed, a bioactive business, have announced a partnership to create functional synbiotic products that are evidence-based and aimed at optimizing the microbiome for proactive and individualized health. To understand the molecular interactions between dietary plants and gut microorganisms and their possible effects on human health, the cooperation uses Brightseed’s artificial intelligence (A.I.) platform, Forager®.

New Production Facility In Valencia, Spain (2023/02/27)

Archer Daniels Midland (ADM) has opened a new production facility in Valencia, Spain, to meet the rising demand for probiotics and postbiotics. The $30 million investment will increase ADM’s production capacity fivefold to 50 metric tons per year. Situated near ADM’s R&D center in the University of Valencia Scientific Park, the facility will leverage advanced technology for genome sequencing and bacterial strain testing. As the world’s first site to produce both probiotics and postbiotics, the facility supports ADM’s growth strategy in the health and wellness sector, aiming to increase revenue from $500 million in 2022 to $2 billion in the next decade. The facility will produce ADM’s proprietary strains, including BPL1™ probiotic and heat-treated BPL1™ postbiotic, catering to the US, Asia-Pacific, and European markets. With the growing awareness of gut microbiome and the demand for science-backed nutrition solutions, ADM expects its customer base to triple in the next five years, aligning with the estimated $10.4 billion growth of the probiotic supplement retail market by 2027.

ADM Q4 Results: Strengthening Focus On Sustainability and Innovation (2023/01/27)

Archer Daniels Midland (ADM) reported impressive financial results for the fourth quarter of 2022, achieving full-year adjusted earnings per share (EPS) of $7.85 and segment operating profit of $6.6 billion. The company also maintained a solid trailing four-quarter average adjusted return on invested capital (ROIC) of 13.6%. ADM’s performance was attributed to its strategic initiatives throughout the year, positioning the company well for future growth. The company generated significant cash flow and returned $2.3 billion to shareholders through dividends and share repurchases. ADM remains committed to mitigating market forces, investing in decarbonization and new food technology platforms, and addressing evolving consumer preferences and food security needs. The company’s focus on sustainability, innovation, and delivering value to shareholders contributes to its continued success.

Photo by Samson on Unsplash 

1 Comment

%d bloggers like this: